PWMG
KROS icon

Private Wealth Management Group’s Keros Therapeutics KROS Stock Holding History

Private Wealth Management Group’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418 Hold
39
– – ﹤0.01% 1411
2026
Q1 		$431 Hold
39
– – ﹤0.01% 1382
2025
Q4 		$795 Sell
39
-63
-62% -$1.1K ﹤0.01% 1312
2025
Q3 		$1.61K Hold
102
– – ﹤0.01% 1175
2025
Q2 		$1.36K Hold
102
– – ﹤0.01% 1193
2025
Q1 		$1.04K Buy
+102
New +$1.18K ﹤0.01% 1257

Other funds holding KROS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Private Wealth Management Group's KROS Position: Q2 2026 in Review

Private Wealth Management Group held its Keros Therapeutics (KROS) position steady in Q2 2026 at 39 shares worth $418. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Private Wealth Management Group first reported a position in KROS in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.61K in Q3 2025. 132 funds tracked by Wall St. Rank hold KROS as of Q2 2026.

  • Private Wealth Management Group held 39 shares of Keros Therapeutics worth $418 as of Q2 2026.
  • Private Wealth Management Group left its Keros Therapeutics share count unchanged in Q2 2026.
  • Keros Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1411 holding.
  • Private Wealth Management Group first reported a position in Keros Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Private Wealth Management Group's Keros Therapeutics position peaked at $1.61K in Q3 2025.
  • 132 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.